1,5-anhydroglucitol Blood Test More Accurate than HbA1c and Glucose for Predicting Mortality COVID-19 Patients with and without Diabetes

November 16, 2021

This week, Precision Diabetes, Inc. presented data demonstrating that the 1,5-anhydroglucitol blood test (GlycoMark®) is more accurate than commonly used diabetes tests in predicting mortality in hospitalized COVID-19 patients with and without diabetes. The study, “1,5-anhydroglucitol is an Independent Predictor of Mortality in Patients with COVID-19,” was presented at the American Heart Association (AHA) 2021 Scientific […]

To view the full Member Resource, please Log in

TOPICS IN THIS ARTICLE:

COVID-19 Diabetes News and Research

Join the Global Movement Advancing Endocrine Science and Medicine

Become a part of a community of 18,000-plus endocrine investigators and clinicians who conduct research and provide quality patient care in more than 100 countries. Advance your career and the field of endocrinology through our many educational, leadership and advocacy opportunities.

Join Today

RELATED ARTICLES

Heroin Adulterated with Diabetes Medication Triggers Life-Threatening Medical Emergencies

Hyperinsulinemia Emerges as Critical Predictor of Severe Liver Outcomes

Father’s Tobacco Use May Raise Children’s Diabetes Risk

Health Topics

Patient Populations